CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.010
-0.090 (-4.29%)
At close: Dec 5, 2025, 4:00 PM EST
2.050
+0.040 (1.99%)
After-hours: Dec 5, 2025, 5:55 PM EST
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $25.68 million as of December 5, 2025. Its market cap has decreased by -45.94% in one year.
Market Cap
25.68M
Enterprise Value
20.07M
1-Year Change
-45.94%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $25.68M, a decrease of -16.08%. That is a compound annual growth rate of -2.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 24.10M | -41.50% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 905.54B |
| Johnson & Johnson | 488.97B |
| AbbVie | 404.64B |
| UnitedHealth Group | 303.18B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 252.67B |
| Abbott Laboratories | 216.21B |